Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5688166 | Kidney International | 2016 | 11 Pages |
Abstract
Proteinuria is one of the first clinical signs of diabetic nephropathy and an independent predictor for the progression to renal failure. Cathepsin L, a lysosomal cysteine protease, can be involved in the development of proteinuria by degradation of proteins that are important for normal podocyte architecture, such as the CD2-associated protein, synaptopodin, and dynamin. Cathepsin L also activates heparanase, a heparan sulfate endoglycosidase previously shown to be crucial for the development of diabetic nephropathy. Here, we evaluated the exact mode of action of cathepsin L in the development of proteinuria in streptozotocin-induced diabetes. Cathepsin L-deficient mice, in contrast to their wild-type littermates, failed to develop albuminuria, mesangial matrix expansion, tubulointerstitial fibrosis, and renal macrophage influx and showed a normal renal function. In wild-type mice the early development of albuminuria correlated with the activation of heparanase and loss of heparan sulfate expression, whereas loss of synaptopodin expression and podocyte damage occurred at a later stage. Thus, cathepsin L is causally involved in the pathogenesis of experimental diabetic nephropathy. Most likely, cathepsin L-dependent heparanase activation is crucial for the development of albuminuria and renal damage.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Marjolein Garsen, Angelique L.W.M.M. Rops, Henry Dijkman, Brigith Willemsen, Toin H. van Kuppevelt, Frans G. Russel, Ton J. Rabelink, Jo H.M. Berden, Thomas Reinheckel, Johan van der Vlag,